本文翻译正在准备中。在此之前，我们暂时显示英文原文。
监管与法律 · 1995/10/191 分钟阅读
Drug Export; AtroventRegister (Ipratropium Bromide) Nasal Spray 0.03%, 10 Milliliter (mL) and 30 mL
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is announcing that Boehringer Ingelheim Pharmaceuticals Inc., has filed an application requesting approval for the export of the human drug Atrovent (ipratropium bromide) Nasal Spray 0.03%, 10 mL and 30 mL to Canada.
来源原始语言: Federal Register — All Documents打开原始公告 →